Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 6, 2023; 11(4): 738-755
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.738
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.738
Characteristics | Univariate analysis | Multivariate analysis | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Age | 1.02 | 1.01-1.04 | 0.002 | 1.03 | 1.02-1.05 | < 0.001 |
Grade | ||||||
G1 | Reference | |||||
G2 | 2.64 | 0.36-19.18 | 0.337 | |||
G3 | 3.53 | 0.49-25.38 | 0.209 | |||
G4 | 3.54 | 0.37-34.07 | 0.274 | |||
Gender | 1.31 | 0.91-1.9 | 0.145 | |||
Stage | ||||||
I | Reference | Reference | ||||
II | 1.45 | 0.75-2.8 | 0.268 | 1.41 | 0.73-2.74 | 0.307 |
III | 2.11 | 1.14-3.91 | 0.018 | 1.99 | 1.07-3.71 | 0.03 |
IV | 3.65 | 1.81-7.39 | < 0.001 | 4.97 | 2.41-10.22 | < 0.001 |
CD93 (high vs low) | 1.6 | 1.09-2.35 | 0.017 | 1.62 | 1.09-2.4 | 0.017 |
- Citation: Li Z, Zhang XJ, Sun CY, Fei H, Li ZF, Zhao DB. CD93 serves as a potential biomarker of gastric cancer and correlates with the tumor microenvironment. World J Clin Cases 2023; 11(4): 738-755
- URL: https://www.wjgnet.com/2307-8960/full/v11/i4/738.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i4.738